VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$11.59
+0.35%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -56.8%
- EBITDA
- +104.4%
- EPS
- +97.9%
Three-year CAGR
- Revenue
- -96.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- -61.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026